Partial Wave Spectroscopic Detection of Colon Cancer Risk
| Status: | Recruiting |
|---|---|
| Conditions: | Colorectal Cancer, Cancer, Colitis, Gastrointestinal |
| Therapuetic Areas: | Gastroenterology, Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/2/2016 |
| Start Date: | March 2010 |
| Contact: | Bonnie Surma, RN |
| Email: | bsurma@medicine.bsd.uchicago.edu |
| Phone: | 773-702-5055 |
The purpose of this study is to study samples of rectal mucosa (the moist lining of the
rectum) using a new light scattering technology, called partial wave spectroscopy (PWS) in
patients who will undergo a standard of care colonoscopy or a flexible sigmoidoscopy and
have a history of ulcerative colitis (UC).
rectum) using a new light scattering technology, called partial wave spectroscopy (PWS) in
patients who will undergo a standard of care colonoscopy or a flexible sigmoidoscopy and
have a history of ulcerative colitis (UC).
The purpose of this study is to study samples of rectal mucosa (the moist lining of the
rectum) using a new light scattering technology, called partial wave spectroscopy (PWS)in
patients who will undergo a colonoscopy or a flexible sigmoidoscopy and have a history of
ulcerative colitis (UC). PWS has been recently developed to allow scientists to learn about
any changes to the cells that may indicate a risk of developing colon cancer. We believe
that the PWS test will more accurately detect the risk of colon cancer.
rectum) using a new light scattering technology, called partial wave spectroscopy (PWS)in
patients who will undergo a colonoscopy or a flexible sigmoidoscopy and have a history of
ulcerative colitis (UC). PWS has been recently developed to allow scientists to learn about
any changes to the cells that may indicate a risk of developing colon cancer. We believe
that the PWS test will more accurately detect the risk of colon cancer.
Inclusion Criteria:
- Patient must be 18 years old or older.
- Patient is already scheduled for a standard of care colonoscopy or flexible
sigmoidoscopy.
- Patient has not received chemotherapy.
- History of ulcerative colitis.
Exclusion Criteria:
- Patient is unable to give informed consent..
- Patient has received chemo or radiation therapy within the past 3 months.
We found this trial at
1
site
Click here to add this to my saved trials
